Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14740%2F21%3A00119422" target="_blank" >RIV/00216224:14740/21:00119422 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00159816:_____/21:00074834

Výsledek na webu

<a href="https://link.springer.com/article/10.1007%2Fs00702-021-02381-5" target="_blank" >https://link.springer.com/article/10.1007%2Fs00702-021-02381-5</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00702-021-02381-5" target="_blank" >10.1007/s00702-021-02381-5</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges

Popis výsledku v původním jazyce

Several neurological diseases are accompanied by rhythmic oscillatory dysfunctions in various frequency ranges and disturbed cross-frequency relationships on regional, interregional, and whole brain levels. Knowledge of these disease-specific oscillopathies is important mainly in the context of deep brain stimulation (DBS) therapy. Electrophysiological biomarkers have been used as input signals for adaptive DBS (aDBS) as well as preoperative outcome predictors. As movement disorders, particularly Parkinson's disease (PD), are among the most frequent DBS indications, the current research of DBS is the most advanced in the movement disorders field. We reviewed the literature published mainly between 2010 and 2020 to identify the most important findings concerning the current evolution of electrophysiological biomarkers in DBS and to address future challenges for prospective research.

Název v anglickém jazyce

Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges

Popis výsledku anglicky

Several neurological diseases are accompanied by rhythmic oscillatory dysfunctions in various frequency ranges and disturbed cross-frequency relationships on regional, interregional, and whole brain levels. Knowledge of these disease-specific oscillopathies is important mainly in the context of deep brain stimulation (DBS) therapy. Electrophysiological biomarkers have been used as input signals for adaptive DBS (aDBS) as well as preoperative outcome predictors. As movement disorders, particularly Parkinson's disease (PD), are among the most frequent DBS indications, the current research of DBS is the most advanced in the movement disorders field. We reviewed the literature published mainly between 2010 and 2020 to identify the most important findings concerning the current evolution of electrophysiological biomarkers in DBS and to address future challenges for prospective research.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30210 - Clinical neurology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Neural Transmission

ISSN

0300-9564

e-ISSN

—

Svazek periodika

128

Číslo periodika v rámci svazku

8

Stát vydavatele periodika

AT - Rakouská republika

Počet stran výsledku

7

Strana od-do

1169-1175

Kód UT WoS článku

000671636200001

EID výsledku v databázi Scopus

2-s2.0-85109829248